Citation Impact
Citing Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
2000 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer.
2001
The Wellcome Foundation Lecture, 1980 - Monoclonal antibodies from hybrid myelomas
1981 StandoutNobel
Helper and killer T cells do not express B cell immunoglobulin joining and constant region gene segments.
1980
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Adjuvant Chemotherapy After Radical Hysterectomy for Cervical Carcinoma: A Comparison With Effects of Adjuvant Radiotherapy
1998
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Cancer of the Ovary
1993
Combination Photoimmunotherapy and Cisplatin: Effects on Human Ovarian Cancer Ex Vivo
1999
Photodynamic therapy for cancer
2003 Standout
Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy
1992
Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 cases
1989
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
2005 Standout
Epirubicin
1993
Superficially invasive squamous cell carcinoma of the cervix
1992
Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer
1991
Cervical cancer
2019 Standout
Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis
2002 Standout
Preclinical phase II study of ifosfamide in human tumour xenografts in vivo
1990
Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: A pilot study
1992
Cancer of the Ovary
2004 Standout
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
2010 StandoutNobel
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.
1979 StandoutNobel
Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice.
1978 StandoutNobel
Isolated hapten‐binding receptors of sensitized lymphocytes I. Receptors from nylon wool‐enriched mouse T lymphocyte lack serological markers of immunoglobulin constant domain but express heavy chain variable portions
1977
Immunological Surveillance of Tumors in the Context of Major Histocompatibility Complex Restriction of T Cell Function
1984 StandoutNobel
The Murine T Cell Antigen Receptor and Associated Structures
1984 StandoutNobel
Radiological Evaluation of Lymph Node Metastases in Patients With Cervical Cancer
1997
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation
1984
The mouse T cell receptor: Structural heterogeneity of molecules of normal T cells defined by Xenoantiserum
1983 StandoutNobel
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
A monoclonal antibody that detects a V kappa-TEPC15 idiotypic determinant cross-reactive with a Thy-1 determinant.
1981
Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors.
1980 StandoutNobel
Helper and suppressor T cell factors
1980 StandoutNobel
The Immune Response Genes of the Major Histocompatibility Complex
1978 StandoutNobel
The genetic and cellular basis of antigen and receptor stimulated regulation
1980 StandoutNobel
Complete sequence of constant and 3′ noncoding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing
1978 StandoutNobel
Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies.
1979 StandoutNobel
Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix
1980
Immunoglobulin‐like messenger RNA in a mouse T cell lymphoma
1977
Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung
1985 StandoutNobel
Recent Advances in Histocompatibility Immunogenetics
1979 StandoutNobel
Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences
1984 StandoutNatureNobel
A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes
1984 StandoutNatureNobel
Chromosomal Locations of the Murine T-Cell Receptor Alpha-Chain Gene and the T-Cell Gamma Gene
1985 StandoutScienceNobel
The T lymphocyte antigen receptor—paradigm lost
1982 Nature
Feedback suppression of the immune response in vitro. II. IgVH-restricted antibody-dependent suppression.
1980 StandoutNobel
Development and Loss of Virus‐Specific Thymic Competence in Bone Marrow Radiation Chimeras and Normal Mice
1981 StandoutNobel
Plasmacytomas, lymphomas and hybridomas: Their contribution to immunology and molecular biology
1980
Isolation of membrane associated immunoglobulins from T lymphocytes by non-ionic detergents
1976
Antigen Receptors of T Helper Cells
1977
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
The Role of Antigen-Specific T Cell Factors in the Immune Response
1980
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
1983 Standout
A T15-idiotype-positive T suppressor hybridoma does not use the T15 VH gene segment.
1982 StandoutNobel
Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes
1981 StandoutNatureNobel
Direct demonstration of murine thymus-dependent cell surface endogenous immunoglobin.
1977
Shared idiotypic determinants on antibodies and T-cell-derived suppressor factor specific for the random terpolymer L-glutamic acid60-L-alanine30-L-tyrosine10.
1979 StandoutNobel
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
T Cells, T Cell Recognition Structures, and the Major Histocompatibility Complex
1978 StandoutNobel
Studies on Hapten Specific T Cell Immunity and Suppression
1980 StandoutNobel
Works of H. Pickel being referenced
[Malignant transformation of condylomata acuminata of the vulva].
1971
[Chemotherapy of malignant ovarian tumors].
1977
Efficacy of Adjuvant Carboplatinum-Epirubicin Chemotherapy in Advanced Ovarian Cancer after Radical Surgery
1989
Nongenital cancers metastatic to the ovary
1992
Prognostic factors in cervical cancer
1997
In vitro chemosensitivity testing in the treatment of ovarian carcinoma
1989
Immunochemical study of an immunoglobulin-like molecule of murine thymocytes
1976
1 The spread of ovarian cancer
1989
Immunofluorescence analysis of Ig determinants of mouse thymocytes and T cells
1976
Local spread and lymph node involvement in cervical cancer.
1978
29 Adjuvant chemotherapy after radical hysterectomy for cervical cancer
1988